A new approach to using stem cells for multiple sclerosis (MS) treatment has been tried at Northwestern University of Chicago. Dr. Richard Burton and colleagues treated the worst form of MS. This is called relapsing-remitting multiple sclerosis. It is known to lead to early disabiliti
A multicenter, phase II trial from Genova, Italy has been completed on 21 patients with severe multiple sclerosis (MS), published in March, 2015. These were patients whose MS was not under control despite conventional MS treatments. They developed new brain lesions that were documente